Abstract:A series of novel O-((3-arylisoxazol-5-yl) methyl) oxime derivatives were synthesized by highly regioselective dipolar cycloadditions of nitrile oxides with (E)-1-arylethan-1-one O-prop-2-yn-1-yl oxime substrates. Results showed that in the formation of (E)-N-hydroxy-3,4-dimethoxybenzimidoyl chloride, chlorinating substitution in phenyl occurred when excess N-chlorosuccinimide. The crystal structure of 10 among the series of compounds revealed it was cis-cyclization product and moiety of -C(CH3)=N-O- was E configuration. As a triclinic crystal, the twist angle between the isoxazol-5-yl ring (B) and phenyl ring (A) was 57.43°, at dihedral angles of 25.22°. Screening for anti-HBV activities of these compounds was carried out. The results showed compounds 11, 19 and 12 effectively inhibited HBeAg (IC50 =158.28± 0.02, 127.51± 0.01, and 213.26± 0.04 respectively). Compounds 11, 19 and 23 manifested stronger inhibition on HBsAg (IC50=12.68± 0.06, 61.24± 0.02, and 89.59± 0.02 μM respectively). Compound 15 was the effctivest inhibition of DNA replication (IC50=43.52±0.02 μM) among the compounds. Docking study of bioactive compounds with HBV core protein (3KXS) was carried out to explore their interaction.This study determined a new non-nucleoside analogs with inhibition of HBV.

Synthesis and Anti-Hepatitis B Virus Activity of Novel Benzimidazole Derivatives

Design and Synthesis of Novel Benzimidazole Derivatives As Inhibitors of Hepatitis B Virus

Discovery of 5-Alkyl-2-pyrazol-oxazolidin-4-one Derivatives As Novel Hepatitis B Virus Capsid Assembly Modulators

Synthesis and anti-hepatitis B virus activity of a novel class of thiazolylbenzimidazole derivatives.

Identification of 1-isopropylsulfonyl-2-amine benzimidazoles as a new class of inhibitors of hepatitis B virus.

Synthesis of Janus Type Nucleoside Analogues and Their Preliminary Bioactivity

Synthesis and Anti‐HBV Activities Evaluation of New Ethyl 8‐imidazolylmethyl‐7‐hydroxyquinoline‐3‐carboxylate Derivatives in Vitro

Synthesis and in Vitro Anti-Hepatitis B Virus Activity of 6H-[1]Benzothiopyrano[4,3-b]quinolin-9-ols.

Synthesis and Anti-HBV Activity of Novel Dihydropyrimidine Analogs

Synthesis and In‐Vitro Anti‐Hepatitis‐B Virus Activity of 6h‐[1]benzothiopyrano[4,3‐b] Quinolin‐10‐ols

Study on 2-arylthio-5-iodo pyrimidine derivatives as novel nonnucleoside inhibitors against hepatitis B virus DNA replication.

Synthesis and Antiviral Activity of New Acrylamide Derivatives Containing 1,2,3-Thiadiazole As Inhibitors of Hepatitis B Virus Replication

Design, synthesis, and biological evaluation of novel (E)-1-arylethan-1-one O-((3-arylisoxazol-5-yl) methyl) oxime derivatives as potent non-nucleoside HBV inhibitors

Synthesis and Anti-HBV Activity of Novel 3′-N-phenylsulfonyl Docetaxel Analogs

Design, synthesis and biological evaluation of novel dihydrobenzodioxine derivatives as HBV capsid protein inhibitors

Design, Synthesis and Bioactive Evaluation of Oxime Derivatives of Dehydrocholic Acid as Anti-Hepatitis B Virus Agents

Optimization and Synthesis of Pyridazinone Derivatives As Novel Inhibitors of Hepatitis B Virus by Inducing Genome-free Capsid Formation

Design, Synthesis, and Antiviral Properties of 2-Aryl-1h-benzimidazole-4-carboxamide Derivatives

Benzimidazole Derivative, BM601, a Novel Inhibitor of Hepatitis B Virus and HBsAg Secretion

Synthesis and in vitro anti-hepatitis B virus activity of six-membered azanucleoside analogues.

Development of Benzimidazole-Based Compounds As Novel Capsid Assembly Modulators for the Treatment of HBV Infection